Hani M. Babiker, MD, is an Assistant Professor of Medicine and Director of Phase I Clinical Trials, University of Arizona Cancer Center and a Clinical Assistant Professor in the Clinical Translational Research Division at TGen. He is board-certified in Medical Oncology, Hematology, Internal Medicine, and Geriatrics and Gerontology. He completed a drug development scholarship at the Virginia G Piper Cancer Center/HonorHealth Research Institute in Scottsdale where he was the principal investigator and sub-investigator in many early clinical trials in solid tumors. Dr Babiker was an instructor in medicine at the Mayo Clinic College of Medicine in Phoenix. He completed a Hematology/ Medical Oncology Fellowship at the University of Arizona.
His research interests are in new drug development and in the treatment of gastrointestinal cancers with an emphasis on pancreatic, cholangiocarcinoma, and colon cancers. He also conducts early clinical trials in prostate cancer. He also has an interest both in developing new biomarkers and targeted therapies in pancreatic cancer.
Chandana, S., H. M. Babiker, and D. Mahadevan,
"Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).",
Expert Opin Investig Drugs, vol. 28, issue 2, pp. 161-177, 2019 Feb.